# Paul M. Ridker

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/paul-m-ridker/

## Facts

| Field | Value |
| --- | --- |
| Citations | 231,490 |
| Field | Lipoproteins and Cardiovascular Health |
| h-index | 225 |
| i10-index | 891 |
| Last Known Institution | Brigham and Women's Hospital |
| OpenAlex ID | https://openalex.org/A5091595592 |
| ORCID iD | https://orcid.org/0000-0003-1249-4522 |
| Works | 1,376 |

## Researcher papers

Showing 12 of 20.

- [Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease](https://scholariq.org/papers/antiinflammatory-therapy-with-canakinumab-for-atherosclerotic-disease/)
- [C-Reactive Protein Levels and Outcomes after Statin Therapy](https://scholariq.org/papers/c-reactive-protein-levels-and-outcomes-after-statin-therapy/)
- [Interpretation of the evidence for the efficacy and safety of statin therapy](https://scholariq.org/papers/interpretation-of-the-evidence-for-the-efficacy-and-safety-of-statin-therapy/)
- [Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease](https://scholariq.org/papers/genetic-risk-adherence-to-a-healthy-lifestyle-and-coronary-disease/)
- [Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/effect-of-interleukin-1-inhibition-with-canakinumab-on-incident-lung-cancer-in/)
- [Low-Dose Methotrexate for the Prevention of Atherosclerotic Events](https://scholariq.org/papers/low-dose-methotrexate-for-the-prevention-of-atherosclerotic-events/)
- [Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk](https://scholariq.org/papers/effect-of-high-dose-omega-3-fatty-acids-vs-corn-oil-on-major-adverse/)
- [Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial](https://scholariq.org/papers/relationship-of-c-reactive-protein-reduction-to-cardiovascular-event-reduction/)
- [Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins](https://scholariq.org/papers/association-of-ldl-cholesterol-non-hdl-cholesterol-and-apolipoprotein-b-levels/)
- [The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials](https://scholariq.org/papers/the-benefits-of-statins-in-people-without-established-cardiovascular-disease-but/)
- [Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials](https://scholariq.org/papers/efficacy-and-safety-of-statin-therapy-in-older-people-a-meta-analysis-of/)
- [IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial](https://scholariq.org/papers/il-6-inhibition-with-ziltivekimab-in-patients-at-high-atherosclerotic-risk/)

## Researcher topics

- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)
- [Adipokines, Inflammation, and Metabolic Diseases](https://scholariq.org/topics/adipokines-inflammation-and-metabolic-diseases/)
- [Diabetes, Cardiovascular Risks, and Lipoproteins](https://scholariq.org/topics/diabetes-cardiovascular-risks-and-lipoproteins/)
- [Atherosclerosis and Cardiovascular Diseases](https://scholariq.org/topics/atherosclerosis-and-cardiovascular-diseases/)
- [Genetic Associations and Epidemiology](https://scholariq.org/topics/genetic-associations-and-epidemiology/)

## Researcher university

- [Brigham and Women's Hospital](https://scholariq.org/institutions/brigham-and-women-s-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
